Dennis Slater

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Lymphoblastic lymphoma in adults.

Dennis Slater, R Mertelsmann, Benjamín Koziner et al. · Journal of Clinical Oncology · 1986 · 114 citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +12

Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis

Susan R. Kahn, Jim A. Julian, Clive Kearon et al. · Journal of Vascular Surgery Venous and Lymphatic Disorders · 2019 · 84 citations · Full text

Thrombosis, Pulmonary Embolism, Venous Disease +10

SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

Hossein Borghaei, Filippo de Marinis, Daphne W. Dumoulin et al. · Annals of Oncology · 2023 · 78 citations · Full text

Nivolumab Versus Docetaxel, Medicine, Pharmacology +7

Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral–Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial

Clive Kearon, Chu‐Shu Gu, Jim A. Julian et al. · Thrombosis and Haemostasis · 2019 · 66 citations